Macrogenics Inc (MGNX): Operating Cash Flow
-$81.04M
Year ended 2025-12-31
-$63.72M
Trailing 12 months to 2026-06-30
| Period ended | Operating Cash Flow | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$81.04M | n/m | 2026-03-09, From 2025-01-01 |
| 2024-12-31 | -$68.37M | n/m | 2026-03-09, From 2024-01-01 |
| 2023-12-31 | -$78.20M | n/m | 2026-03-09, From 2023-01-01 |
| 2022-12-31 | -$86.96M | n/m | 2025-03-20, From 2022-01-01 |
| 2021-12-31 | -$143.83M | n/m | 2024-03-07, From 2021-01-01 |
| 2020-12-31 | -$111.90M | n/m | 2023-03-15, From 2020-01-01 |
| 2019-12-31 | -$134.27M | n/m | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | -$153.23M | n/m | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $14.40M | n/a | 2020-02-25, From 2017-01-01 |
| No annual figure between 2013-12-31 and 2017-12-31. | |||
| 2013-12-31 | -$14.17M | n/m | 2014-03-20, From 2013-01-01 |
| 2012-12-31 | -$6.58M | n/m | 2014-03-20, From 2012-01-01 |
| 2011-12-31 | $6.76M | n/a | 2014-03-20, From 2011-01-01 |
Operating Cash Flow at similar companies
| Company | Year ended | Operating Cash Flow | Change YoY |
|---|---|---|---|
| Macrogenics Inc (MGNX) | 2025-12-31 | -$81.04M | n/m |
| Elite Pharmaceuticals Inc (ELTP) | 2026-03-31 | $23.75M | +218.5% |
| Karyopharm Therapeutics Inc. (KPTI) | 2025-12-31 | -$75.37M | n/m |
| Heron Therapeutics, Inc. (HRTX) | 2025-12-31 | -$27.59M | n/m |
| Liquidia Corp (LQDA) | 2025-12-31 | -$35.69M | n/m |
| Syndax Pharmaceuticals Inc (SNDX) | 2025-12-31 | -$322.98M | n/m |
| Lifecore Biomedical, Inc. (LFCR) | 2025-05-25 | -$206.0K | n/m |
| Phathom Pharmaceuticals, Inc. (PHAT) | 2025-12-31 | -$166.78M | n/m |
| Cryoport, Inc. (CYRX) | 2025-12-31 | -$8.58M | n/m |
Compare MGNX, ELTP, KPTI, HRTX side by side · Screen every company in Pharmaceutical Preparations ↗